JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: Assessment of value in a series of 664 consecutive patients

Animesh Pardanani, Terra L. Lasho, Kebede Hussein, Susan M. Schwager, Cristy M. Finke, Rajiv K. Pruthi, Ayalew Tefferi

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: Assessment of value in a series of 664 consecutive patients'. Together they form a unique fingerprint.

Medicine & Life Sciences